Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had revenue of $162.05M in the quarter ending March 31, 2026, with 106.87% growth. This brings the company's revenue in the last twelve months to $535.08M, up 128.99% year-over-year. In the year 2025, Tarsus Pharmaceuticals had annual revenue of $451.36M with 146.71% growth.

• Revenue (ttm): $535.08M
• Revenue Growth: +128.99%
• P/S Ratio: 5.01
• Revenue / Employee: $1,446,159
• Employees: 370
• Market Cap: 2.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	451.36M	268.41M	146.71%
Dec 31, 2024	182.95M	165.51M	948.62%
Dec 31, 2023	17.45M	-8.37M	-32.42%
Dec 31, 2022	25.82M	-31.21M	-54.73%
Dec 31, 2021	57.03M	-	-

Data Source: S&P Global Market Intelligence Last updated: Feb 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error